Prevalence, Outcome, and Optimal Management of Free-Floating Right Heart Thrombi in the Context of Pulmonary Embolism, a Systematic Review and Meta-Analysis
- PMID: 36384306
- PMCID: PMC9677292
- DOI: 10.1177/10760296221140114
Prevalence, Outcome, and Optimal Management of Free-Floating Right Heart Thrombi in the Context of Pulmonary Embolism, a Systematic Review and Meta-Analysis
Abstract
Free-floating right-heart thrombus (FFRHT) in the context of a pulmonary embolism (PE) is a rare but serious encounter with no guidelines addressing its management. We performed a systematic review and meta-analysis addressing prevalence, clinical behavior, and outcomes of FFRHT associated with PE. Among the included 397 patients with FFRHT and PE, dyspnea was the main presenting symptom (73.3%). Obstructive shock was documented in 48.9% of cases. Treatment with thrombolytic therapy, surgical thrombectomy, and percutaneous thrombectomy was documented in 43.8%, 32.7%, and 6.5% of patients, respectively. The overall mortality rate was 20.4%. Syncope (p: 0.027), chest pain (p: 0.006), and obstructive shock (p: 0.037) were significantly associated with mortality. Use of thrombolytic therapy was significantly associated with survival (p: 0.008). A multivariate logistic regression model to determine mortality predictors revealed that syncope (OR: 1.97, 95% CI: 1.06-3.65, p: 0.03), and obstructive shock (OR: 2.23, 95% CI: 1.20-4.14, p: 0.01) were associated with increased death odds. Treatment with thrombolytic therapy (OR: 0.22, 95% CI: 0.086-0.57, p: 0.002) or surgical thrombectomy (OR: 0.35, 95% CI: 0.137-0.9, p: 0.03) were associated with reduced death odds. Meta-analysis of observational studies revealed a pooled prevalence of FFRHT among all PE cases of 8.1%, and overall mortality of 23%. Although uncommon, the presence of FFRHT in the context of PE is associated with high obstructive shock and mortality rates. Favorable survival odds are observed with thrombolytic therapy and surgical thrombectomy. Data are derived from case reports and observational studies. Clinical trials elucidating these findings are needed.
Keywords: free-Floating right heart thrombi; pulmonary embolism; right heart thrombi.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis.Thromb Res. 2022 Sep;217:86-95. doi: 10.1016/j.thromres.2022.07.013. Epub 2022 Jul 29. Thromb Res. 2022. PMID: 35926347
-
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938605 Free PMC article.
-
Thrombolysis for acute ischaemic stroke.Cochrane Database Syst Rev. 2003;(3):CD000213. doi: 10.1002/14651858.CD000213. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000213. doi: 10.1002/14651858.CD000213.pub2. PMID: 12917889 Updated.
-
Impact of Time to Catheter-Based Therapy on Outcomes in Acute Pulmonary Embolism.Circ Cardiovasc Interv. 2025 Jan;18(1):e014499. doi: 10.1161/CIRCINTERVENTIONS.124.014499. Epub 2025 Jan 21. Circ Cardiovasc Interv. 2025. PMID: 39836740
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
Cited by
-
The latest in the management of pulmonary embolism.Breathe (Sheff). 2025 Jun 17;21(2):240100. doi: 10.1183/20734735.0100-2024. eCollection 2025 Apr. Breathe (Sheff). 2025. PMID: 40529311 Free PMC article. Review.
-
Right atrial thrombus leading to pulmonary embolism in a patient with dermatomyositis and COVID-19 managed with FlowTriever device thrombectomy.BMJ Case Rep. 2023 Nov 9;16(11):e255385. doi: 10.1136/bcr-2023-255385. BMJ Case Rep. 2023. PMID: 37945279
-
Right heart thrombus in acute pulmonary embolism: A single center experience in China.Pulm Circ. 2023 Sep 20;13(3):e12291. doi: 10.1002/pul2.12291. eCollection 2023 Jul. Pulm Circ. 2023. PMID: 37744669 Free PMC article.
-
Percutaneous thrombectomy with the FlowTriever for pulmonary embolism with right heart thrombi: a retrospective two centres study.Eur Heart J Open. 2024 Nov 22;4(6):oeae092. doi: 10.1093/ehjopen/oeae092. eCollection 2024 Nov. Eur Heart J Open. 2024. PMID: 39582754 Free PMC article. No abstract available.
-
A Prospective Cross-Sectional Cohort Study on Factors Associations With Right Heart Thrombi and Pulmonary Embolism.Health Sci Rep. 2025 May 7;8(5):e70825. doi: 10.1002/hsr2.70825. eCollection 2025 May. Health Sci Rep. 2025. PMID: 40342959 Free PMC article.
References
-
- Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340-1347. - PubMed
-
- Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. Br Med J. 2020;370:m2177. - PubMed
-
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical